The global Gene Vector market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Gene Vector is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Gene Vector is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Gene Vector in Scientific Research is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Gene Vector include Lonza, Merck KGaA, Oxford Biomedica, CGT Catapult, Charles River Laboratories, uniQure N.V., FUJIFILM Diosynth Biotechnologies and Spark Therapeutics, Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Vector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Vector.
The Gene Vector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gene Vector market comprehensively. Regional market sizes, concerning products by vector type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Vector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by vector type, by application, and by regions.
By Company
Lonza
Merck KGaA
Oxford Biomedica
CGT Catapult
Charles River Laboratories
uniQure N.V.
FUJIFILM Diosynth Biotechnologies
Spark Therapeutics, Inc.
Segment by Vector Type
Lentivirus
Adenovirus
Adeno-associated Virus (AAV)
Plasmid DNA
Others
Segment by Application
Scientific Research
CRO
CDMO
Others (Pharmaceutical, Biotechnology Companies)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by vector type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Vector companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by vector type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Vector Type
1.2.1 Global Gene Vector 麻豆原创 Size Growth Rate by Vector Type: 2018 VS 2022 VS 2029
1.2.2 Lentivirus
1.2.3 Adenovirus
1.2.4 Adeno-associated Virus (AAV)
1.2.5 Plasmid DNA
1.2.6 Others
1.3 麻豆原创 by Application
1.3.1 Global Gene Vector 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Scientific Research
1.3.3 CRO
1.3.4 CDMO
1.3.5 Others (Pharmaceutical, Biotechnology Companies)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Vector 麻豆原创 Perspective (2018-2029)
2.2 Gene Vector Growth Trends by Region
2.2.1 Global Gene Vector 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Vector Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Gene Vector Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Gene Vector 麻豆原创 Dynamics
2.3.1 Gene Vector Industry Trends
2.3.2 Gene Vector 麻豆原创 Drivers
2.3.3 Gene Vector 麻豆原创 Challenges
2.3.4 Gene Vector 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Vector Players by Revenue
3.1.1 Global Top Gene Vector Players by Revenue (2018-2023)
3.1.2 Global Gene Vector Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Gene Vector 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Vector Revenue
3.4 Global Gene Vector 麻豆原创 Concentration Ratio
3.4.1 Global Gene Vector 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Vector Revenue in 2022
3.5 Gene Vector Key Players Head office and Area Served
3.6 Key Players Gene Vector Product Solution and Service
3.7 Date of Enter into Gene Vector 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Vector Breakdown Data by Vector Type
4.1 Global Gene Vector Historic 麻豆原创 Size by Vector Type (2018-2023)
4.2 Global Gene Vector Forecasted 麻豆原创 Size by Vector Type (2024-2029)
5 Gene Vector Breakdown Data by Application
5.1 Global Gene Vector Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Gene Vector Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Gene Vector 麻豆原创 Size (2018-2029)
6.2 North America Gene Vector 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Vector 麻豆原创 Size by Country (2018-2023)
6.4 North America Gene Vector 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Vector 麻豆原创 Size (2018-2029)
7.2 Europe Gene Vector 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Vector 麻豆原创 Size by Country (2018-2023)
7.4 Europe Gene Vector 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Vector 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Gene Vector 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Vector 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Gene Vector 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Vector 麻豆原创 Size (2018-2029)
9.2 Latin America Gene Vector 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Vector 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Gene Vector 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Vector 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Gene Vector 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Vector 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Gene Vector 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Gene Vector Introduction
11.1.4 Lonza Revenue in Gene Vector Business (2018-2023)
11.1.5 Lonza Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Gene Vector Introduction
11.2.4 Merck KGaA Revenue in Gene Vector Business (2018-2023)
11.2.5 Merck KGaA Recent Development
11.3 Oxford Biomedica
11.3.1 Oxford Biomedica Company Detail
11.3.2 Oxford Biomedica Business Overview
11.3.3 Oxford Biomedica Gene Vector Introduction
11.3.4 Oxford Biomedica Revenue in Gene Vector Business (2018-2023)
11.3.5 Oxford Biomedica Recent Development
11.4 CGT Catapult
11.4.1 CGT Catapult Company Detail
11.4.2 CGT Catapult Business Overview
11.4.3 CGT Catapult Gene Vector Introduction
11.4.4 CGT Catapult Revenue in Gene Vector Business (2018-2023)
11.4.5 CGT Catapult Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Detail
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Gene Vector Introduction
11.5.4 Charles River Laboratories Revenue in Gene Vector Business (2018-2023)
11.5.5 Charles River Laboratories Recent Development
11.6 uniQure N.V.
11.6.1 uniQure N.V. Company Detail
11.6.2 uniQure N.V. Business Overview
11.6.3 uniQure N.V. Gene Vector Introduction
11.6.4 uniQure N.V. Revenue in Gene Vector Business (2018-2023)
11.6.5 uniQure N.V. Recent Development
11.7 FUJIFILM Diosynth Biotechnologies
11.7.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.7.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.7.3 FUJIFILM Diosynth Biotechnologies Gene Vector Introduction
11.7.4 FUJIFILM Diosynth Biotechnologies Revenue in Gene Vector Business (2018-2023)
11.7.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.8 Spark Therapeutics, Inc.
11.8.1 Spark Therapeutics, Inc. Company Detail
11.8.2 Spark Therapeutics, Inc. Business Overview
11.8.3 Spark Therapeutics, Inc. Gene Vector Introduction
11.8.4 Spark Therapeutics, Inc. Revenue in Gene Vector Business (2018-2023)
11.8.5 Spark Therapeutics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Lonza
Merck KGaA
Oxford Biomedica
CGT Catapult
Charles River Laboratories
uniQure N.V.
FUJIFILM Diosynth Biotechnologies
Spark Therapeutics, Inc.
听
听
*If Applicable.
